Essential Partners
AVNS icon

Essential Partners’s Avanos Medical AVNS Stock Holding History

Essential Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-25
Closed -$622 – 2867
2026
Q2 		$622 Sell
25
-2,281
-99% -$53.4K ﹤0.01% 2423
2026
Q1 		$32.3K Buy
2,306
+31
+1% +$418 0.01% 743
2025
Q4 		$25.5K Sell
2,275
-1,415
-38% -$16.2K 0.01% 819
2025
Q3 		$42.7K Buy
3,690
+2,801
+315% +$32.8K 0.01% 639
2025
Q2 		$10.9K Buy
+889
New +$11.2K ﹤0.01% 823

Other funds holding AVNS

Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
B
Bayban Bayport, Minnesota $130M AUM 21.7% 1-Year Est. Return

Essential Partners's AVNS Position: Q3 2026 in Review

Essential Partners sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 25 shares — an estimated $622 sold.

Essential Partners first reported a position in AVNS in Q2 2025 and held it in 5 quarters. The position peaked at $42.7K in Q3 2025. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Essential Partners reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Essential Partners sold 25 Avanos Medical shares in Q3 2026, an estimated $622.
  • Essential Partners first reported a position in Avanos Medical in Q2 2025 and held it in 5 quarters.
  • Essential Partners's Avanos Medical position peaked at $42.7K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.